🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the present study is to understand the neurobiological mecha...
Status
Terminated
Location
University of Chicago
Start Date
2016-10
Trial ID
NCT02770768
Treatments Being Tested
The purpose of this study is to determine if it is feasible for women to ta...
Status
Active Not Recruiting
Location
Norwalk Hospital
Start Date
2018-09-14
Trial ID
NCT03707340
Treatments Being Tested
To generate additional long-term safety and efficacy data on flibanserin in...
Status
Terminated
Location
511.133.01074 Boehringer Ingelheim Investigational Site
Start Date
2010-04
Trial ID
NCT01103362
Treatments Being Tested
To establish efficacy of Flibanserin 50 Milligrams Daily and 100 Milligrams...
Status
Completed
Location
511.77.43005 Boehringer Ingelheim Investigational Site
Start Date
2007-06
Trial ID
NCT00491829
The object of this trial is to assess the safety and efficacy of a 24 week ...
Status
Completed
Location
511.147.01074 Boehringer Ingelheim Investigational Site
Start Date
2009-10
Trial ID
NCT00996164
Treatments Being Tested
The current trial will explore the safety of flibanserin in combination wit...
Status
Terminated
Location
Clinical Innovations
Start Date
2010-01
Trial ID
NCT01040208
Treatments Being Tested
The objective of this trial is to assess the safety and efficacy of 24-week...
Status
Completed
Location
511.130.01074 Boehringer Ingelheim Investigational Site
Start Date
2009-10
Trial ID
NCT00996372
Treatments Being Tested
This trial is designed to assess the safety and efficacy of flibanserin in ...
Status
Completed
Location
511.71.01034 Boehringer Ingelheim Investigational Site
Start Date
2006-07
Trial ID
NCT00360529
Treatments Being Tested
The objective of this trial is to assess the safety and efficacy of 24-week...
Status
Terminated
Location
511.156.01059 Boehringer Ingelheim Investigational Site
Start Date
2010-01
Trial ID
NCT01057901
Treatments Being Tested
Unblinded study of flibanserin for 8 weeks with responders randomized 1:1 t...
Status
Terminated
Location
San Diego Sexual Medicine
Start Date
2017-01-25
Trial ID
NCT02714049
Treatments Being Tested